Similar articles

• Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis.

  Aagaard CS, Hoang TT, Vingsbo-Lundberg C, Dietrich J, Andersen P. Aagaard CS, et al. J Immunol. 2009 Aug 15;183(4):2659-68. doi: 10.4049/jimmunol.0900947. Epub 2009 Jul 20. J Immunol. 2009. PMID: 19620314
• Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection.

  Palendira U, Spratt JM, Britton WJ, Triccas JA. Palendira U, et al. Vaccine. 2005 Feb 25;23(14):1680-5. doi: 10.1016/j.vaccine.2004.10.007. Vaccine. 2005. PMID: 15705472
• Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.

  Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N. Badell E, et al. Vaccine. 2009 Jan 1;27(1):28-37. doi: 10.1016/j.vaccine.2008.10.034. Epub 2008 Oct 31. Vaccine. 2009. PMID: 18977269
• The influence of age on immunity to infection with Mycobacterium tuberculosis.

  Vesosky B, Turner J. Vesosky B, et al. Immunol Rev. 2005 Jun;205:229-43. doi: 10.1111/j.0105-2896.2005.00257.x. Immunol Rev. 2005. PMID: 15882357 Review.
• Reactivation of tuberculosis by tumor necrosis factor neutralization.

  Jacobs M, Samarina A, Grivennikov S, Botha T, Allie N, Fremond C, Togbe D, Vasseur V, Rose S, Erard F, Monteiro A, Quesniaux V, Ryffel B. Jacobs M, et al. Eur Cytokine Netw. 2007 Mar;18(1):5-13. doi: 10.1684/ecn.2007.0083. Epub 2007 Mar 30. Eur Cytokine Netw. 2007. PMID: 17400533 Review.